Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Inflammation markers detect neonatal sepsis:

This article was originally published in Clinica

Executive Summary

Testing for two markers of inflammation could help doctors make an early diagnosis of sepsis in newborns, according to a study in Pediatrics (July). The markers CD11b and IL-8 (interleukin 8) were found to be present at low levels in the blood of healthy infants, but at high levels in all but three infants with neonatal sepsis. Neonatal sepsis is a life-threatening infection that affects as many as 1% of newborns, according to study leader, Dr Irmeli Nupponen, of the University of Helsinki.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT072080

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel